Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induction of Mucosal Tolerance to E-Selectin for the Secondary Prevention of Stroke

NCT00012454 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.

NCT NCT00012454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00012454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induction of Mucosal Tolerance to E-Selectin for the Secondary Prevention of Stroke
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2001
Completion date
February 29, 2004
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident, transient ischemic attack